Dose–Response Relationship for Image-Guided Stereotactic Body Radiotherapy of Pulmonary Tumors: Relevance of 4D Dose Calculation
- 31 October 2008
- journal article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 74 (1), 47-54
- https://doi.org/10.1016/j.ijrobp.2008.06.1939
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Outcomes of Risk-Adapted Fractionated Stereotactic Radiotherapy for Stage I Non–Small-Cell Lung CancerInternational Journal of Radiation Oncology*Biology*Physics, 2008
- Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non–small-cell lung cancerInternational Journal of Radiation Oncology*Biology*Physics, 2006
- Stereotactic body radiation therapy for nonmetastatic lung cancer: An analysis of 75 patients treated over 5 yearsInternational Journal of Radiation Oncology*Biology*Physics, 2006
- Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer—Mature results for medically inoperable patientsLung Cancer, 2006
- Stereotactic body radiation therapy of early-stage non–small-cell lung carcinoma: Phase I studyInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancerLung Cancer, 2005
- Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: A noninvasive treatment approach in medically inoperable patientsInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Clinical outcomes of stereotactic radiotherapy for stage I non-small cell lung cancer using a novel irradiation technique: patient self-controlled breath-hold and beam switching using a combination of linear accelerator and CT scannerLung Cancer, 2004
- Stereotactic body frame based fractionated radiosurgery on consecutive days for primary or metastatic tumors in the lungLung Cancer, 2003
- Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experienceInternational Journal of Radiation Oncology*Biology*Physics, 2001